Select Bibliography

Filter by any of these (after searching):

Williams, Terence

AUTHOR ABSTRACT DEADLINES

A meeting abstract must be submitted by the first or corresponding author to the Alliance Publications Coordinator (publications@AllianceNCTN.org) at least two weeks prior to the meeting abstract submission deadline. For detailed information about Alliance Publications guidelines, please refer to the policies, along with the author abstract deadlines.

There are 3 items

A Randomized Phase II Trial of Atezolizumab with or without Tiragolumab Before and After Definitive Chemoradiation for Unresectable Stage III NSCLC (AFT-57)

Ross, Helen J. , Kozono, David , Mix, Michael , Urbanic, James ... - ASCO - J Clin Oncol - 2024

Abstract - No-Endpoint - Trial-Description-Only - Respiratory - AFT-57

Phase II Trial of Atezolizumab Before and After Definitive Chemoradiation for Patients with Unresectable Stage III NSCLC

Ross, Helen J. , Kozono, David , Urbanic, James , Williams, Terence ... - IASLC (WCLC) - J Thorac Oncol - 2017

Abstract - No-Endpoint - Trial-Description-Only - Respiratory - AFT-16

ALLIANCE A082002 -A RANDOMIZED PHASE II/III TRIAL OF MODERN IMMUNOTHERAPY-BASED SYSTEMIC THERAPY WITH OR WITHOUT SBRT FOR PD-L1-NEGATIVE, ADVANCED NON-SMALL CELL LUNG CANCER

SCHILD, STEVEN E. , WANG, XIAOFEI , BESTVINA, CHRISTINE M. ... - - Clin Lung Cancer - 2022

Manuscript - No-Endpoint - Trial-Description-Only - Respiratory - Alliance-A082002